Amelioration of Cognitive Dysfunction in Diabetic Rats by Jianpi Qinghua Prescription
10.13422/j.cnki.syfjx.20230138
- VernacularTitle:健脾清化方对糖尿病大鼠认知功能障碍的改善作用
- Author:
Qiuyue GUO
1
;
Yanna GENG
2
;
Xu HAN
1
;
Jing TIAN
1
;
Jie LI
3
;
Qingguang CHEN
1
;
Hao LU
1
Author Information
1. Diabetes Institute， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine（TCM）， Shanghai 201203， China
2. Hebei Provincial Hospital of TCM， Shijiazhuang 130100， China
3. Medical School， Shandong University of Traditional Chinese Medicine， Jinan 250355， China
- Publication Type:Journal Article
- Keywords:
Jianpi Qinghua prescription;
diabetes mellitus;
cognitive dysfunction;
amyloid β-protein;
tau protein phosphorylation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(8):195-202
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the amelioration of cognitive dysfunction in diabetes mellitus （DM） by Jianpi Qinghua prescription （JPQH） based on type 2 diabetes （T2DM） model rats. MethodFifty healthy male Wistar rats of SPF grade were randomly divided into control group （n=10） and experimental group （n=40）. The rats in the control group were fed conventionally， while those in the experimental group were fed on a high-sugar， high-fat diet for six weeks and administered with streptozotocin （STZ） for the induction of the DM model. The model rats were randomly divided into model group， sitagliptin group （1.2 g·L-1）， pioglitazone group （0.8 g·L-1）， and JPQH group （1.3 g·mL-1）， with 10 rats in each group. After six weeks of drug intervention， the changes in body weight， blood glucose， and other related indexes of each group were recorded. Enzyme-linked immunosorbent assay （ELISA） was performed to detect the levels of tumor necrosis factor-α （TNF-α）， interleukin-1β （IL-1β）， and interleukin-6 （IL-6） in the peripheral blood and brain. The Morris water maze test was used to evaluate the cognitive function in rats. Hematoxylin-eosin （HE） staining was used to observe the pathological morphology of the hippocampal CA region. The amyloid β-protein 40 （Aβ40） level was detected by immunohistochemistry. The protein expression of t-tau and p-tau in hippocampal neurons of rats was detected by Western blot. ResultCompared with blank group， the body weight of model group was significantly decreased （P<0.05）， blood glucose level was significantly increased （P<0.01）， inflammatory cytokines TNF-α and IL-1β were increased （P<0.05）， learning and spatial ability were significantly decreased （P<0.01）， the arrangement of hippocampal cells was loose and disordered， and the intercellular space was significantly increased. The number of cells decreased significantly， and the expression of Aβ40 increased significantly. and increased t-tau and p-tau protein content in the hippocampus （P<0.01）. Compared with model group， the JPQH group showed reduced blood glucose （P<0.01）， decreased TNF-α and IL-1β levels in the peripheral blood and cerebrospinal fluid （P<0.05）， a downward trend of IL-6 without a statistical difference， improved learning and spatial memory ability （P<0.01）， densely arranged cells in the hippocampal CA1 area， increased cell number， reduced Aβ40 expression， and decreased p-tau protein expression （P<0.05）. ConclusionJPQH can prevent cognitive dysfunction in DM by reducing inflammatory factor levels， decreasing neurotoxicity caused by Aβ40 deposition， and inhibiting hyperphosphorylation of tau protein in DM rats.
